Melatonin enhances arsenic trioxide-induced cytotoxicity by modulating autophagy in an acute promyelocytic leukemia cell line

BACKGROUND: Arsenic trioxide (ATO)-containing therapeutic strategies are widely used in the treatment of acute promyelocytic leukemia (APL). Growing evidence has shown that melatonin enhances the radio- or chemo-sensitivity of numerous cancer cells. However, whether melatonin is capable of enhancing...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xia, Pu, Xin, Yang, Sainan, Meng, Xiaoqin, Chen, Xue, Zhang, Zhihua, Sheng, Xaomin, Xiang, Dan, Zhang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797307/
https://www.ncbi.nlm.nih.gov/pubmed/35116957
http://dx.doi.org/10.21037/tcr.2019.09.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797307/
https://www.ncbi.nlm.nih.gov/pubmed/35116957
http://dx.doi.org/10.21037/tcr.2019.09.26

Ejemplares similares